1. Home
  2. EYE vs NRIX Comparison

EYE vs NRIX Comparison

Compare EYE & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • EYE
  • NRIX
  • Stock Information
  • Founded
  • EYE 1990
  • NRIX 2009
  • Country
  • EYE United States
  • NRIX United States
  • Employees
  • EYE N/A
  • NRIX N/A
  • Industry
  • EYE Ophthalmic Goods
  • NRIX Biotechnology: Pharmaceutical Preparations
  • Sector
  • EYE Health Care
  • NRIX Health Care
  • Exchange
  • EYE Nasdaq
  • NRIX Nasdaq
  • Market Cap
  • EYE 900.5M
  • NRIX 1.1B
  • IPO Year
  • EYE 2017
  • NRIX 2020
  • Fundamental
  • Price
  • EYE $17.17
  • NRIX $9.50
  • Analyst Decision
  • EYE Buy
  • NRIX Strong Buy
  • Analyst Count
  • EYE 7
  • NRIX 17
  • Target Price
  • EYE $17.14
  • NRIX $30.71
  • AVG Volume (30 Days)
  • EYE 2.8M
  • NRIX 942.9K
  • Earning Date
  • EYE 05-07-2025
  • NRIX 04-08-2025
  • Dividend Yield
  • EYE N/A
  • NRIX N/A
  • EPS Growth
  • EYE N/A
  • NRIX N/A
  • EPS
  • EYE N/A
  • NRIX N/A
  • Revenue
  • EYE $1,850,850,000.00
  • NRIX $56,417,000.00
  • Revenue This Year
  • EYE $6.62
  • NRIX $15.73
  • Revenue Next Year
  • EYE $2.62
  • NRIX N/A
  • P/E Ratio
  • EYE N/A
  • NRIX N/A
  • Revenue Growth
  • EYE N/A
  • NRIX N/A
  • 52 Week Low
  • EYE $9.56
  • NRIX $8.18
  • 52 Week High
  • EYE $19.49
  • NRIX $29.56
  • Technical
  • Relative Strength Index (RSI)
  • EYE 84.04
  • NRIX 35.33
  • Support Level
  • EYE $12.98
  • NRIX $9.02
  • Resistance Level
  • EYE $12.51
  • NRIX $11.56
  • Average True Range (ATR)
  • EYE 0.63
  • NRIX 0.61
  • MACD
  • EYE 0.56
  • NRIX -0.07
  • Stochastic Oscillator
  • EYE 98.74
  • NRIX 14.29

About EYE National Vision Holdings Inc.

National Vision Holdings Inc is an optical retailer in the U.S. Its product portfolio includes eyeglasses and sunglasses, contact lenses, accessories, and other products. The company has two operating segments; Owned and Host segment includes company-owned brands America's Best and Eyeglass World, In America's Best stores, vision care services are provided by optometrists or by independent professional corporations and Host operating consist of Military and Fred Meyer which provide eye exams by independent optometrists, and the Legacy segment manages the operations of, and supplies inventory and lab processing services to Legacy retail Vision Centers. It earns a majority of its revenue from the Owned and Host segment.

About NRIX Nurix Therapeutics Inc. Common stock

Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.

Share on Social Networks: